Departments of Neurosurgery and.
J Neurosurg. 2014 Jul;121(1):4-11. doi: 10.3171/2014.4.JNS131662. Epub 2014 May 16.
OBJECT.: The purpose of this study was to report the authors' experiences in stent-assisted coil embolization (SAC) of ruptured wide-necked aneurysms in the acute period and to evaluate the incidence of and risk factors for periprocedural complications.
A total of 72 patients were recruited for this study between March 2007 and June 2012. All patients met the following criteria: 1) the presence of ruptured intracranial wide-necked saccular aneurysms, and 2) the patient underwent SAC for treatment of those aneurysms within 72 hours of rupture. All of the patients with clinically poor grades or acute hydrocephalus underwent external ventricular drainage (EVD) before SAC. The incidence of and risk factors for periprocedural complications were retrospectively evaluated.
Of the 72 patients included in this study, periprocedural complications occurred in 14 (19.4%), including asymptomatic complications in 4 (5.6%) and symptomatic complications in 10 (13.9%); there were symptomatic thromboembolic complications in 5 patients (6.9%), and symptomatic hemorrhagic complications in 5 (6.9%). The authors observed no subacute or delayed thromboembolic complications during the follow-up period of 18.8 months. Use of EVD (OR 1.413, 95% CI 0.088-2.173; p = 0.046) was the only independent risk factor for periprocedural complications on multivariate logistic regression analysis.
The periprocedural complication rate during SAC was 19.4% among 72 patients. Because of the high complication rate, microsurgical clipping or endovascular treatment with another technique (multiple-microcatheter or balloon-assisted technique) may be a more appropriate option for first-line treatment than SAC, especially in patients requiring EVD.
本研究旨在报告作者在急性破裂宽颈动脉瘤中进行支架辅助线圈栓塞(SAC)的经验,并评估围手术期并发症的发生率和危险因素。
2007 年 3 月至 2012 年 6 月,共招募了 72 名符合条件的患者。所有患者均符合以下标准:1)存在破裂的颅内宽颈囊状动脉瘤;2)在破裂后 72 小时内进行 SAC 治疗。所有临床分级较差或急性脑积水的患者在 SAC 前均进行了外引流(EVD)。回顾性评估围手术期并发症的发生率和危险因素。
在本研究的 72 名患者中,有 14 名(19.4%)发生围手术期并发症,其中无症状并发症 4 例(5.6%),有症状并发症 10 例(13.9%);有症状血栓栓塞性并发症 5 例(6.9%),有症状出血性并发症 5 例(6.9%)。在 18.8 个月的随访期间,未观察到亚急性或迟发性血栓栓塞并发症。多变量逻辑回归分析显示,使用 EVD(OR 1.413,95%CI 0.088-2.173;p = 0.046)是围手术期并发症的唯一独立危险因素。
72 例患者中,SAC 围手术期并发症发生率为 19.4%。由于并发症发生率较高,对于需要 EVD 的患者,与 SAC 相比,显微手术夹闭或另一种技术(多微导管或球囊辅助技术)的血管内治疗可能是更合适的一线治疗选择。